Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a prevalent and potentially fatal disease categorized based on its high incidences and mortality rates, which raised the need for effective diagnostic strategies for the early detection and management of CRC. While there are several conventional cancer diagnostics available, they have certain limitations that hinder their effectiveness. Significant research efforts are currently being dedicated to elucidating novel methodologies that aim at comprehending the intricate molecular mechanism that underlies CRC. Recently, microfluidic diagnostics have emerged as a pivotal solution, offering non-invasive approaches to real-time monitoring of disease progression and treatment response. Microfluidic devices enable the integration of multiple sample preparation steps into a single platform, which speeds up processing and improves sensitivity. Such advancements in diagnostic technologies hold immense promise for revolutionizing the field of CRC diagnosis and enabling efficient detection and monitoring strategies. This article elucidates several of the latest developments in microfluidic technology for CRC diagnostics. In addition to the advancements in microfluidic technology for CRC diagnostics, the integration of artificial intelligence (AI) holds great promise for further enhancing diagnostic capabilities. Advancements in microfluidic systems and AI-driven approaches can revolutionize colorectal cancer diagnostics, offering accurate, efficient, and personalized strategies to improve patient outcomes and transform cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Schematic illustration (A1,A2) Integrated microfluidic device for CTC enrichment and analysis (B1,B2) Development of Integrated Microfluidic Device for Simultaneous Enrichment and Analysis of Circulating Tumor Cells, (C1) Comparative Immuno-staining Analysis of Captured Cells in PBS and Human Blood Samples [81]. (Reproduced with permission from Su, W.; Yu, H.; Jiang, L.; Chen, W.; Li, H.; Qin, J, Disease Markers; published by Hindawi, 2019).](https://figures.cochat.ai/paper-figures/1fd715b4e8834ceca3a27c166a357f64/current-status-and-emerging-trends-in-colorectal-cancer-screening-and-figure-5.jpg)
![Figure 6 Schematic representation illustrating the underlying mechanism of enzyme-aided fluorescence amplification based on GO-DNA aptamer interactions for exosome detection (Image taken from: Reproduced with permission from Wang, H.; Chen, H.; Huang, Z.; Li, T.; Deng, A.; Kong, J. Ta-lanta; published by Elsevier, 2018 [87].](https://figures.cochat.ai/paper-figures/82bd840d41c14274bae7fb6369102714/current-status-and-emerging-trends-in-colorectal-cancer-screening-and-figure-6.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434 · cited 1×
“Recent epidemiological data from 2020 to 2021 reported a mortality rate of 9.4%, accompanied by a noteworthy increase in incidents among the elderly [2].”
BackgroundInfluentialEpidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Rawla, P., Sunkara, T., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.81072 · Cited by 2,323
Microfluidic diagnostic technologies for global public health
Yager, P., Edwards, T., Fu, E., Helton, K., Nelson, K., Tam, M. R., & Weigl, B. H. (2006) · Nature · doi:10.1038/nature05064 · Cited by 1,979
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900 · cited 1×
“…can identify specific molecular changes that are indicative of CRC or By analyzing alterations in genes or DNA regions known to be linked to CRC, these tests can identify speci fi c molecular changes that are indicative of CRC or advanced adenomas. biomarkers associated with CRC development [21].”
BackgroundTrevethan, R. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00307 · Cited by 1,616
Ethical and legal challenges of artificial intelligence-driven healthcare
Gerke, S., Minssen, T., & Cohen, G. (2020) · Artificial Intelligence in Healthcare · doi:10.1016/b978-0-12-818438-7.00012-5 · Cited by 1,170 · cited 1×
“Addressing these concerns effectively is imperative to facilitate adoption [111].”
BackgroundLin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-analysis
Lee, J. K., Liles, E. G., Bent, S., Levin, T. R., & Corley, D. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1484 · Cited by 707 · cited 1×
“…demonstrates up to 79% sensitivity and 94% specificity, reflecting its efficacy as a screening modality for detecting CRC prior to symptoms [19] and contributing to Among these, FIT demonstrates up to 79% sensitivity and 94% speci fi city, re fl ecting its e ffi cacy as a robust screening…”
BackgroundLin, J. S., Piper, M. A., Perdue, L. A., Rutter, C. M., Webber, E. M., O’Connor, E., Smith, N., & Whitlock, E. P. (2016) · JAMA · doi:10.1001/jama.2016.3332 · Cited by 693
Colorectal cancer screening: An updated review of the available options
Issa, I. A., & Noureddine, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i28.5086 · Cited by 572
Cited by
Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
Pandey, S., & Yadav, P. K. (2024) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2024.e00446 · Cited by 131
Hemdan, M., Abuelhaded, K., Shaker, A. A. S., Ashour, M. M., Abdelaziz, M. M., Dahab, M. I., Nassar, Y. A., Sarguos, A. M. M., Zakaria, P. S., Fahmy, H. A., et al. (2025) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2025.100783 · Cited by 56
Eslami, M., Naderian, R., Bahar, A., Babaeizad, A., Gheshlagh, S. R., Oksenych, V., & Tahmasebi, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1559480 · Cited by 60
Risk factors, prevention and screening of colorectal cancer: A rising problem
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, J. L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i5.98629 · Cited by 42
AI-powered liquid biopsy for early detection of gastrointestinal cancers
Hussain, M. S., Rejili, M. S., Khan, A., Alshammari, S. O., Tan, C. S., Haouala, F., Ashique, S., & Alshammari, Q. A. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120484 · Cited by 31
Metadata
- Authors
- Beniwal, S., Lamo, P., Kaushik, A., Lorenzo-Villegas, D., Liu, Y., & MohanaSundaram, A.
- Affiliations
- Lady Hardinge Medical College (IN)
- Universidad Internacional de La Rioja (ES)
- Florida Polytechnic University (US)
- Universidad Fernando Pessoa Canarias (ES)
- Mayo Clinic (US)
- Sathyabama Institute of Science and Technology (IN)
- Corresponding author
- Liu, Yuguang
- MohanaSundaram, ArunSundar
- ORCID
- Venue
- Biosensors
- Publisher
- MDPI AG
- Published
- 2023-10-13
- Volume
- 13
- Issue
- 10
- Pages
- 926
- ISSN
- 2079-6374 (ISSN-L)
- PMC
- PMC10605407
- OpenAlex
- W4387642583
- Semantic Scholar
- 83019e80b94cab903d85130811d1120c47c81c75
- Cited by
- 60
- References
- 112
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 19
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biosensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Re-Unir (International University of La Rioja) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Keywords
- colorectal cancer, cancer screening, cancer diagnosis, microfluidics, artificial intelligence, early detection, non-invasive diagnosis, treatment response monitoring
- MeSH terms
- Artificial Intelligence, Humans, Technology, Colorectal Neoplasms, Microfluidics, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. https://app.cochat.ai/papers/10.3390/bios13100926
- The paper
- Beniwal, S., Lamo, P., Kaushik, A., Lorenzo-Villegas, D., Liu, Y., & MohanaSundaram, A. (2023). Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics. Biosensors. https://doi.org/10.3390/bios13100926
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.